168P Liver metastases (mets) and treatment effect of cemiplimab-based therapy: An analysis from three phase III trials (EMPOWER-Lung 1, EMPOWER-Lung 3 part 2, and EMPOWER-Cervical 1)

Saved in:
Bibliographic Details
Published inImmuno-oncology technology Vol. 16; p. 100280
Main Authors Baramidze, A., Gessner, C., Gogishvili, M., Sezer, A., Makharadze, T., Kilickap, S., Gumus, M., Tewari, K.S., Monk, B.J., de Melo, A.C., Oaknin, A., Li, S., Gao, B., Mathias, M.D., Gullo, G., Salvati, M.E., Seebach, F., Lowy, I., Fury, M., Rietschel, P.
Format Journal Article
LanguageEnglish
Published 01.12.2022
Online AccessGet full text

Cover

More Information
ISSN:2590-0188
2590-0188
DOI:10.1016/j.iotech.2022.100280